FDA recall, , Low risk
Eugia Lidocaine HCl Injection
Lidocaine HCl Injection has a label wrap that covers the barcode, making it hard to scan.
Summary by Recall Canary from the FDA notice
What happened
Eugia US LLC of East Windsor, New Jersey is recalling Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. The label wrap covers the barcode, making it hard to scan. The recall began on May 18, 2026, and the FDA added it to the Enforcement Report on May 29, 2026.
The product was distributed nationwide in the US. The recall involves 168,300 vials.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
- NDC
- 55150-164-02
- Lot code
- 3LC26029A
- Feb-2029
- 3LC26031A
- Mar-2029
Recall details
- Company began the recall
- Sold in
US Nationwide.
- Company
- Eugia US LLCEast Windsor, New Jersey
- Hazard
- Labeling error
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99024
- Recall number
- D-0552-2026
- Quantity recalled
- 168,300 vials
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
